{"url_path":"/sec/evfm/8-k/2026-07-14/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-033184-index.html","accession_number":"0001493152-26-033184","cik":"0001618835","ticker":"EVFM","issuer_name":"Evofem Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-033184-index.html","primary_entity_key":"0001618835","primary_entity_name":"Evofem Biosciences, Inc."},"word_count":42,"has_tables":true,"body_markdown":"**Item 2.03 Creation of a Direct Financial Obligation\nor an Obligation under an Off-Balance Sheet Arrangement of a Registrant**\n\n \n\nThe information disclosed\nin item 1.01 of this Current Report on Form 8-K is incorporated into this item 2.03 to the extent required."}